Health Policy OPEN卫生政策开放
Health Policy OPEN(英文缩写 HEALTH POLICY OPEN),ISSN 2590-2296,eISSN 2590-2296,中文译名:卫生政策开放 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-10-01 至 2026-09-30，按本站收录文献的发表日期统计。
期刊介绍
Health Policy OPEN 最新收录文献
-
1. Stroke team workforce maldistribution in indonesia: a burden-based policy analysis.
PMID:日期:2026-09-18Stroke is Indonesia's leading cause of disability, yet workforce planning relies on population-based norms, risking territorial inequities in access to essential services. To examine the ecological alignment between provincial stroke burden and key stroke team workforce availability, and to test the robustness of a proposed burden-based planning indicator. Cross-sectional ecological policy analysis across 34 provinces combining Global Burden of Disease Study 2023 DALYs with 2025 administrative data on neurologists, neurosurgeons, and physiotherapists. Burden-to-workforce ratios assessed service pressure; robustness was tested against an alternative indicator specification, alternative statistical classification methods, and formal comparison with population-based fulfillment metrics. Substantial geographic mismatches exist between need and availability. Eight provinces (23.5%) were classified High Pressure for each cadre (neurologists, neurosurgeons, physiotherapists) individually, while the overall bottleneck classification (worst cadre per province) flagged 11 provinces (32.4%) as High Pressure. Four provinces (North Kalimantan, West Sulawesi, Gorontalo, West Papua) reported zero practicing neurosurgeons. Provinces with comparable stroke burden displayed up to 26.3-fold differences in neurologist workforce capacity. Burden-based classification correlated weakly with population-based fulfillment metrics (Spearman's ρ = 0.35, = 0.044) and showed only 41.2% categorical agreement, indicating the two approaches frequently identify different priority provinces. Indonesia's stroke workforce distribution shows a structural, ecologically observed mismatch with subnational disease burden. Cautious integration of burden-based indicators such as DALYs alongside conventional population-based metrics may support more equitable workforce planning; prospective validation and multi-country testing are warranted before broader adoption.
-
2. Systemic readiness and policy gaps for metabolic syndrome care in botswana prisons: A national WHO building blocks evaluation.
PMID:日期:2026-09-08Metabolic syndrome is a growing global health challenge, affecting one in four adults worldwide, with prevalence in sub-Saharan Africa estimated at 20-30%. In Botswana, urban prevalence is 27%, reflecting a high burden of NCDs. Prisoners are particularly vulnerable due to overcrowding, poor nutrition, sedentary confinement, and limited access to health services. To evaluate the systemic capacity, effectiveness, and readiness of Botswana's prison health care delivery mechanisms in managing metabolic syndrome, focusing on diagnostic, treatment, and continuity-of-care protocols. A descriptive cross-sectional study was conducted across all 20 prison health facilities in Botswana. A structured questionnaire adapted from the WHO Service Availability and Readiness Assessment (SARA) tool was administered to healthcare providers. Composite scores were generated to produce a Facility Readiness Index (FRI). Service delivery and health information systems demonstrated moderate readiness, with most facilities maintaining chronic disease registers and reporting NCD statistics. Workforce shortages were pronounced, particularly in health posts, which relied heavily on single nurses. Medicines and equipment were moderately available, but frequent stock-outs of insulin, oral hypoglycemics, and inhalers undermined continuity of care. Governance and financing emerged as the weakest domains, with half of facilities lacking standard operating procedures and only 20% reporting dedicated budgets for NCD care. The overall FRI was 58%, indicating low-to-moderate systemic readiness. Botswana's prison health system demonstrates significant gaps in readiness for metabolic syndrome care. Strengthening diagnostic capacity, workforce training, medicine supply chains, and integration with national health systems is essential to safeguard prisoner health and broader public health outcomes.
-
3. Pharmaceutical-industry R&D and hospital financial performance in Japan: a fixed-effects analysis.
PMID:日期:2026-08-20Rising pharmaceutical prices and increasing research and development (R&D) expenditure by pharmaceutical companies have raised concerns about hospital financial sustainability worldwide. Nevertheless, evidence on the association between pharmaceutical-industry R&D expenditure and hospital financial performance remains limited. To examine whether the associations between pharmaceutical-industry R&D expenditure and hospital financial performance differ between the special functioning hospital category, which provides advanced medical care, and other hospital categories. This study integrated annual financial data for four institutionally defined hospital categories with firm-level R&D data for listed pharmaceutical companies. Hospital data were obtained from a national survey by Japan's Ministry of Health, Labour and Welfare. Firm-level R&D data from NEEDS-Financial QUEST 2.0, eol, and company disclosures were aggregated into an industry-level measure aligned with the hospitals' fiscal year. Hospital-category fixed-effects models were used in the analyses. The association between pharmaceutical-industry R&D expenditure and the pharmaceutical cost ratio was more positive for the special functioning hospital category than for the other categories. The association with the medical operating margin was also more negative for this category. Higher R&D expenditure was associated with less favorable financial indicators for the special functioning hospital category than for the other categories. These findings suggest that hospitals providing advanced medical care may face greater financial pressures related to pharmaceutical R&D and high-cost medicines, although hospital-level evidence is needed to confirm this interpretation.
-
4. The impact of the United States most favored nation policies on prices of branded medicines and research and development.
4. 美国最惠国政策对品牌药品价格及研发的影响PMID:日期:2026-08-06The Executive Order (EO) reintroducing the Most Favored Nation (MFN) policy sets out measures to lower prices of branded medicines in the United States (US) and increase them elsewhere. To understand the impact of the policy on prices and on pharmaceutical innovation, this paper reviews empirical literature on historic price trends in the US and other high-income countries, the impact of international reference pricing (IRP), and the impact of regulation and market conditions on Research and Development (R&D). 49 studies were included. List prices are greater in the US than other high-income countries, and the difference in net prices has widened in the last two decades. The IRP literature indicates that for some drugs, MFN might be able to reduce prices in the US and increase them in reference countries, particularly for drugs where Medicare and Medicaid have a high global market share. In other cases, firms may strategically delay or cancel launch in other countries to avoid price comparisons. It is likely that MFN will provoke a reduction in global pharma revenues and aggregate investment in R&D. A few countries are increasing prices as part of trade deals with the US. If countries do not wish to increase prices, then they should expect, and prepare for, slower pharma innovation. From a public health perspective, it is not just aggregate R&D that matters, but whether R&D investment is directed to projects which are likely to promote the greatest health gain.
-
5. Improving financial protection and access: Managing co-payments for outpatient prescription medicines through digital technologies in Estonia.
PMID:日期:2026-06-30Estonian households faced persistent financial hardship due to high out-of-pocket payments for outpatient prescription medicines. An "additional medicine benefit" was therefore introduced in 2003, which lowers co-payments once a person's spending for outpatient prescription medicine has reached a threshold. However uptake remained low due to administrative hurdles and lack of awareness. In response, Estonia reformed this benefit in 2018, including leveraging digital technologies to automate eligibility checks and benefit provision at the point of sale. This paper explores how Estonia developed, designed and implemented these digital technologies and analyses the reform's observed changes. This study employed a qualitative-dominant mixed-methods approach, including document reviews, key informant interviews, and analysis of administrative data from the Estonian Health Insurance Fund (EHIF). The WHO framework for assessing digital technologies in health financing guided data collection and thematic analysis. Built on Estonia's e-prescription system, the reform included lowering co-payment thresholds coupled with automating a member's benefit and enabling related real-time data exchange. The share of patients benefitting rose from 0.4% in 2017 to 15.6% in 2018, which is assumed to have contributed to decreasing the incidence of catastrophic health spending during the same time. Automation has significantly reduced the administrative burdens for EHIF, pharmacists and patients. Estonia's experience demonstrates how digital technologies support health financing reforms, contributing to increased efficiency, improved financial protection and utilization aligned with need. Yet, there is further potential to use existing data and digital technologies to better target benefits to those most in need.
-
6. What drives family physicians to rural practice? A discrete choice experiment in Vietnam.
PMID:日期:2026-06-20Despite commune health stations serving as the backbone of Vietnam's primary healthcare, severe physician maldistribution persists. To explore factors influencing the recruitment and retention of family physicians in rural areas, we conducted a discrete choice experiment among 315 family physicians in Vietnam. Mixed logit regression was used to estimate the relative importance of individual characteristics and key job attributes, which included and Our findings indicate that a 50% increase in salary has the most significant influence on rural job uptake for key subgroups, including those under 50, assistant doctors, and those with prior rural exposure. However, the marginal utility of financial incentives diminishes rapidly beyond a specific threshold. Subgroup analysis further reveals heterogeneous preferences: physicians who transitioned from commune health stations to higher-level facilities, and those working in primary health care areas, respond more strongly to non-financial incentives such as career promotion and private practice support than to additional income increases. Physicians would forgo 48.36% of their salary to secure an urban posting, yet would accept a rural position if offered expedited promotion or private practice support, each valued at approximately 38% of monthly income. Achieving sustainable rural deployment therefore requires differentiated rather than uniform intervention: moderate salary increases for younger and rural-exposed physicians, combined with accelerated promotion pathways and private practice facilitation for those in primary health care and higher-level facilities. Translating stated preferences into actual rural uptake ultimately hinges on government credibility in delivering promised benefits.
-
7. Genres and typologies of standard paediatric service public funding model provisions for speech-language pathology management: A scoping review.
PMID:日期:2026-05-19Successive Australian healthcare policies promoting privatisation have increased demand for independent speech-language pathology (SLP) services. This growth has intensified pressure on healthcare funding mechanisms and highlighted confusion in the literature between health financing systems and healthcare funding provisions at the funding model level. In response, public funding arrangements have increasingly supported access to private SLP services for Australian children and young people. This scoping review aimed to identify and describe current public funding models (PFMs) used to access standard paediatric SLP funding through Australian independent SLP providers. Scoping review methodology was undertaken and incorporated search terms synonymous with funding mechanisms, population-based, block and individualised funding. Iterative searching and screening of three health and two scholarly business databases unveiled eighty-six (n = 86) articles, revealing six genres of PFMs and nine associated typologies. The review identified that seven (n = 7) contemporary PFMs were used to access Australian independent SLP services. Health funding and health financing serve different functions within healthcare systems. Compared with the extensive literature on health financing, research on health funding remains limited. A key contribution of this scoping review was the identification of themes and the systematic classification of PFMs by genre and typology, providing a blueprint for understanding past, current, and future PFMs. Furthermore, mapping Australian independent SLP services across funding models and typologies highlighted the diversity of public funding provisions within Australia. Future research should examine how policy architects can balance increasing demand, integration of the latest scientific evidence-base, and equitable access to SLP services.
-
8. Successes and setbacks in dual HIV/syphilis test scale-up strategies: Lessons learned for testing integration in an era of declining resources.
PMID:日期:2026-05-12With increasingly limited funding availability for global health programmes including the elimination of mother-to-child transmission of HIV, syphilis, and hepatitis B, cost-effective and cost-saving service delivery options such as service integration strategies are vital. The introduction of dual HIV/syphilis rapid diagnostic tests (RDTs) has helped bridge testing gaps by enabling immediate integration of testing for HIV and syphilis. First prequalified by WHO in 2013, widescale adoption of the dual RDTs required extensive global and national advocacy and coordination, including evidence generation, guideline development, engagement across key countries, and shifts in policies, priorities and market dynamics. Price reductions of these commodities -driven by negotiations with manufacturers-accelerated scale-up and led to broader adoption. Global Fund data indicates a rapid increase in dual RDT procurements, while country-level data shows that nations incorporating dual RDTs into antenatal care have significantly improved syphilis testing coverage which is key to eliminating congenital syphilis. Understanding the key enablers that facilitated widescale adoption of dual RDTs as well as ongoing challenges can inform rapid rollout of future multiplex testing products, which may support continued progress toward testing goals through integrated service delivery during funding decreases and shifting priorities.
-
9. Developing a framework for improved data use in health management at the district level in Malawi health management information system.
PMID:日期:2026-04-15The effective use of Health Management Information Systems (HMIS) is critical for strengthening decision-making and resource allocation in healthcare, particularly in low and middle-income countries such as Malawi. Yet, district level data use remains constrained by institutional challenges that undermine the potential of HMIS. This study proposes a framework to enhance data use in health management at the district level, drawing on institutional theory and the dynamics of coercive, normative and mimetic pressures. A qualitative approach was employed, including semi-structured interviews, participant observations, and documents analysis, to examine how these pressures shape data practices within Malawi's health sector. Findings reveal that improved data use depends on key activities such as regulating practices, building human capacity, sustaining efforts, integrating data tools and platforms, coordinating processes and partnerships, motivating contributions, and sharing best practices. By addressing these institutional concerns, the proposed framework offers actionable recommendations for policymakers and practitioners to foster a culture of data use, strengthen health management decision-making, and advance ICT4D scholarship on HMIS effectiveness and health outcomes in low and middle-income settings.
-
10. Determinants of catastrophic healthcare spending in Portugal (2005-2022).
PMID:日期:2026-04-15The study analyses the extent, evolution and impoverishing effects of catastrophic health expenditures (CHE) in Portugal from 2005 to 2022. The analysis also identifies factors associated with the occurrence of CHE. The results show a progressive reduction in financial burden with increased access to healthcare services. CHE incidence decreased from 9.42% (2005) to 5.04% (2022). Reduced access to the Portuguese NHS was associated to increased reliance on private services and out-of-pocket costs. Barriers, unmet needs and challenges regarding the protection of vulnerable groups remain, including the elderly and individuals incapacitated to work. Households with at least one senior show a particular vulnerability to CHE. Regional disparities are reinforced by underdeveloped healthcare infrastructure, limited access and financial barriers.